Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration. (Q42207862)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 June 2012
edit
Language Label Description Also known as
English
Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration.
scientific article published on 25 June 2012

    Statements

    Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit